|  | Cancer | Cancer Treatment

Cancer Treatment Modalities: Surgery, Radiation, Chemotherapy, Immunotherapy, and Emerging Options

Cancer treatment is highly individualized based on cancer type, stage, molecular profile, patient health, and preferences. Multidisciplinary teams (surgical/medical/radiation oncology, pathology, radiology, nursing, supportive care) develop comprehensive plans.

Primary Treatment Modalities

1. Surgery

  • Curative intent: Complete resection with negative margins (R0)
  • Diagnostic/staging: Biopsy, sentinel lymph node mapping
  • Debulking/cytoreduction: Enhances efficacy of adjuvant therapies
  • Palliative: Obstruction relief, hemorrhage control, pain reduction
  • Minimally invasive (laparoscopic, robotic) increasingly standard

2. Radiation Therapy

  • External beam (EBRT): IMRT, VMAT, SBRT/SRS (stereotactic), proton therapy—precision targeting with organ sparing
  • Brachytherapy: Radioactive sources placed inside or adjacent to tumor (prostate, cervix, breast)
  • Used as adjuvant (post-op), neoadjuvant (pre-op), definitive, or palliative

3. Systemic Therapies

Chemotherapy

Cytotoxic drugs targeting rapidly dividing cells. Regimens: adjuvant, neoadjuvant, palliative. Side effects: myelosuppression, neuropathy, alopecia, nausea, fatigue.

Targeted Therapy

Drugs against specific molecular drivers: tyrosine kinase inhibitors (EGFR, ALK, BCR-ABL), monoclonal antibodies (HER2, CD20, VEGF), PARP inhibitors (BRCA), hormone receptor modulators.

Immunotherapy

Immune checkpoint inhibitors (anti-PD-1/PD-L1, anti-CTLA-4), CAR-T cells, bispecific antibodies, cancer vaccines, oncolytic viruses. Durable responses in melanoma, lung, bladder, MSI-high cancers.

Hormone Therapy

Endocrine manipulation for hormone-driven cancers: breast (SERMs, AIs, SERDs), prostate (ADT, ARSI), endometrial.

4. Cellular Therapy

  • Autologous/allogeneic hematopoietic stem cell transplant (leukemia, lymphoma, myeloma)
  • CAR-T cell therapy (B-cell malignancies)

5. Palliative and Supportive Care

Integrated early: pain and symptom management, psychosocial support, advance care planning, survivorship programs. Improves quality of life and may extend survival.

Emerging Frontiers

  • Precision oncology: NGS-guided therapy, liquid biopsy monitoring
  • Antibody-drug conjugates (ADCs)
  • Tumor microenvironment modulation (TGF-β, adenosine, microbiome)
  • AI-driven drug discovery and treatment planning

Decision-Making

Shared decision-making incorporates guidelines (NCCN, ESMO), clinical trial eligibility, patient goals, and geriatric/functional assessment. No single "best" treatment—only the best fit for each patient.

Cancer Treatment - Related Articles